UCSFCancer Profile Banner
UCSF Helen Diller Family Comprehensive Cancer Ctr Profile
UCSF Helen Diller Family Comprehensive Cancer Ctr

@UCSFCancer

Followers
10K
Following
17K
Media
3K
Statuses
14K

Championing basic science, clinical research, epidemiology/cancer control, and patient care. Contact: [email protected]

San Francisco
Joined September 2011
Don't wanna be here? Send us removal request.
@UCSFCancer
UCSF Helen Diller Family Comprehensive Cancer Ctr
4 months
RT @AACR: The overall cancer death rate is declining steadily in the US, and more individuals are living longer and fuller lives after a ca….
0
13
0
@UCSFCancer
UCSF Helen Diller Family Comprehensive Cancer Ctr
4 months
RT @AACR: May is National Cancer Research Month. Dr. LoRusso, AACR Past President, explains how basic research is essential to accelerating….
0
8
0
@UCSFCancer
UCSF Helen Diller Family Comprehensive Cancer Ctr
4 months
“The field as a whole, in the last 10 years, has gone incredibly fast to come up with innovative molecules to target KRAS” @kevansf @UCSF in #AACR25 Keynote | Addressing KRAS Resistance, RAS(ON) Therapies Find Limelight at AACR @aacr
Tweet media one
0
0
3
@UCSFCancer
UCSF Helen Diller Family Comprehensive Cancer Ctr
4 months
Donʻt miss today, May 1st at 4pm: Maria Castro, PhD @castro2355_mg @umich presents "Epigenetic reprogramming of the immune microenvironment in H3G34R pediatric high-grade gliomas" at our Friday Seminar Series @UCSF
Tweet media one
0
1
12
@UCSFCancer
UCSF Helen Diller Family Comprehensive Cancer Ctr
4 months
RT @AACR: We thank the more than 22,000 attendees—including more than 900 virtual attendees—from 81 countries who participated in the AACR….
0
12
0
@UCSFCancer
UCSF Helen Diller Family Comprehensive Cancer Ctr
4 months
RT @AACR: The 2024-2025 recipients of AACR grants presented their work in a special poster session this evening at #AACR25. .
0
4
0
@UCSFCancer
UCSF Helen Diller Family Comprehensive Cancer Ctr
4 months
RT @UCSFGradDiv: Congratulations to UCSF's Sophia Miliotis on taking home first place at the 2025 @UofCalifornia Grad Slam! .
0
5
0
@UCSFCancer
UCSF Helen Diller Family Comprehensive Cancer Ctr
4 months
RT @Tadashi_Manabe: Successfully presented my research on Exarafenib at #AACR25 today. Grateful to the session chairs for their valuable fe….
0
2
0
@UCSFCancer
UCSF Helen Diller Family Comprehensive Cancer Ctr
4 months
Friday, May 1st at 4pm: Maria Castro, PhD @castro2355_mg @umich presents "Epigenetic reprogramming of the immune microenvironment in H3G34R pediatric high-grade gliomas" at our @UCSF Friday Seminar Series in Basic and Translational Research
Tweet media one
1
1
21
@UCSFCancer
UCSF Helen Diller Family Comprehensive Cancer Ctr
4 months
Tues, April 30th 10:15 AM CT | @UCSF at #AACR25 | Xiaokun Shu, PhD, presents "New physical biology of oncoprotein condensates: Differential regulation of the transcriptome by phase separation" at @aacr. Session preview:
Tweet media one
0
1
4
@UCSFCancer
UCSF Helen Diller Family Comprehensive Cancer Ctr
4 months
Wednesday, April 30th 12:39 PM CT | @UCSF at #AACR25 | Plenary Session on meeting highlights and Vision for the Future. Scarlett Gomez, PhD, MPH @UCSF_Epibiostat.will present.
Tweet media one
0
1
1
@UCSFCancer
UCSF Helen Diller Family Comprehensive Cancer Ctr
4 months
RT @YTChou: Catch the @BivonaLabUCSF team at #AACR25 on April 29th!. @Tadashi_Manabe | 2:30–4:00 PM.Minisymposium, Room S102. @YTChou | 2:0….
0
1
0
@UCSFCancer
UCSF Helen Diller Family Comprehensive Cancer Ctr
4 months
RT @UCSF_BCHSI: Kicking off the Frontiers in Computational Health Conference 2025! @UCBerkeley Vice Chancellor for Research, Kathy Yelick -….
0
5
0
@UCSFCancer
UCSF Helen Diller Family Comprehensive Cancer Ctr
4 months
RT @BenHuangLab: Excited to share that our work was published in @JCO_ASCO! A report from the @COGorg: stem cell transplantation is associa….
Tweet card summary image
ascopubs.org
PURPOSEHematopoietic stem cell transplantation (HSCT) is used as consolidation for pediatric patients with high-risk AML in first complete remission (CR1). The definition of high-risk AML has evolved...
0
1
0
@UCSFCancer
UCSF Helen Diller Family Comprehensive Cancer Ctr
4 months
RT @KlebanoffLab: 🚨🧬Everything you wanted to know about actionable #neoantigens resulting from cancer mutations besides point mutations (*b….
0
3
0
@UCSFCancer
UCSF Helen Diller Family Comprehensive Cancer Ctr
4 months
RT @MoffittNews: At the #AACR25 plenary, Matthew Krummel, PhD, (@UCSFCancer) explores therapeutic strategies to reshape the tumor micro- an….
0
6
0
@UCSFCancer
UCSF Helen Diller Family Comprehensive Cancer Ctr
4 months
RT @UCSFHospitals: UCSF neurosurgery experts including Drs. Shawn @HerveyJumper, @robcosorio, Praveen Mummaneni & Dr. Nima Alan presented n….
0
5
0
@UCSFCancer
UCSF Helen Diller Family Comprehensive Cancer Ctr
4 months
RT @CChuMD: Check out our podium at #AUA25 tomorrow discussing upstream regulators of STEAP1 in prostate cancer, presented by Dr. Sasha Zhu….
0
1
0
@UCSFCancer
UCSF Helen Diller Family Comprehensive Cancer Ctr
4 months
RT @Tadashi_Manabe: Excited to present my research on Exarafenib at #AACR25 tomorrow. My work demonstrates promising efficacy against all c….
0
3
0
@UCSFCancer
UCSF Helen Diller Family Comprehensive Cancer Ctr
4 months
Tuesday, April 29th 10:45 AM CT | @UCSF at #AACR25 | Major Symposium: Immunology with Hideho Okada, MD, PhD presenting "Tumor-wide RNA splicing aberrations generate therapeutically actionable public neoantigens" at @aacr
Tweet media one
0
2
5